for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reckitt Benckiser Group Plc

RB.L

Latest Trade

6,602.00GBp

Change

158.00(+2.45%)

Volume

1,186,495

Today's Range

6,456.00

 - 

6,666.00

52 Week Range

5,130.00

 - 

8,020.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
6,444.00
Open
6,488.00
Volume
1,186,495
3M AVG Volume
22.23
Today's High
6,666.00
Today's Low
6,456.00
52 Week High
8,020.00
52 Week Low
5,130.00
Shares Out (MIL)
711.66
Market Cap (MIL)
45,859.45
Forward P/E
19.81
Dividend (Yield %)
2.71

Next Event

Full Year 2020 Reckitt Benckiser Group PLC Earnings Release

Latest Developments

More

Reckitt Benckiser Q3 Like-For-Like Sales Jump 13.3%

Reckitt Benckiser H1 Adj EPS From Cont Ops 166.5 Pence

Reckitt Benckiser Appoints Sami Naffakh As Chief Supply Officer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Reckitt Benckiser Group Plc

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Vanish and Woolite.

Industry

Personal & Household Prods.

Contact Info

103-105 Bath Road

SL1 3UH

United Kingdom

+44.1753.217800

https://www.rb.com

Executive Leadership

Christopher Alan Sinclair

Non-Executive Chairman of the Board

Laxman Narasimhan

Chief Executive Officer, Director

Jeffrey Carr

Chief Financial Officer, Executive Director

Kris Licht

President - Health, Global Chief Customer Officer

Aditya Sehgal

President - Nutrition, President China and E-RB

Key Stats

2.22 mean rating - 23 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2017

11.5K

2018

12.6K

2019

12.8K

2020(E)

14.0K
EPS (GBp)

2017

324.600

2018

339.900

2019

349.000

2020(E)

325.270
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.39
Price To Book (MRQ)
4.59
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
128.42
LT Debt To Equity (MRQ)
112.26
Return on Investment (TTM)
-9.65
Return on Equity (TTM)
-7.46

Latest News

Latest News

Reckitt third-quarter sales top estimates on coronavirus demand for cleaning products

Reckitt Benckiser <RB.L> reported on Tuesday a much bigger-than-expected rise in third-quarter sales and raised its full-year outlook, as the coronavirus pandemic lifts demand for its cleaning products.

FTSE 100 falls as lockdowns, Brexit uncertainty weigh

London's FTSE 100 fell on Tuesday on concerns over tougher coronavirus lockdowns in parts of England and Brexit-related uncertainty, although losses were limited due to upbeat quarterly results from Reckitt Benckiser.

Reckitt Q3 sales up on coronavirus demand for cleaning products

Reckitt Benckiser on Tuesday reported a bigger-than-expected rise in third-quarter sales that were boosted as the coronavirus pandemic spurred demand for cleaning products.

Exclusive: Reckitt kicks off sale of some personal care brands - sources

Consumer goods group Reckitt Benckiser Group <RB.L> is preparing to sell some of its non-core personal care brands, including Veet hair removal cream and Clearasil acne cream, four sources familiar with the matter said on Monday.

Delta teams up with Lysol to innovate on travel hygiene

Delta Air Lines <DAL.N> said on Monday it is teaming up with Reckitt Benckiser Group Plc <RB.L>, the makers of Lysol, to research and develop new disinfecting solutions for high-traffic areas in airports and onboard, with a first focus on airplane lavatories.

Brazilian waste management firm finds cost-cutting users in pandemic

A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser <RB.L> and Siemens AG <SIEGn.DE>, and logistics firm Luft, its chief executive said on Thursday...

U.S. EPA approves use of Lysol Disinfectant Spray against COVID-19

UK-based Reckitt Benckiser Group Plc <RB.L> said on Tuesday that the U.S. Environmental Protection Agency (EPA) has approved use of its Lysol Disinfectant Spray against COVID-19.

Reckitt Benckiser's sales hit record on coronavirus disinfectant boom

Reckitt Benckiser <RB.L> achieved record sales growth in the first quarter and predicted a stronger-than-expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap ahead of the coronavirus lockdowns.

BRIEF-Reckitt Benckiser Posts Record Sales On Disinfectant Boom

* RECKITT - QTRLY REVENUE 3,544 MILLION STG VERSUS 3,157 MILLION STG AS REPORTED A YEAR EARLIER

Lysol maker urges people not to inject disinfectants after Trump remarks

Lysol and Dettol maker Reckitt Benckiser <RB.L> warned people against using disinfectants to treat the coronavirus, after U.S. President Donald Trump suggested researchers try putting disinfectants into patients' bodies.

BRIEF-Reckitt Benckiser Says Co's Disinfectant Products Should Not Be Administered Into Human Body Through Injection, Ingestion, Any Other Route

* RECKITT BENCKISER- CO'S DISINFECTANT PRODUCTS SHOULD NOT BE ADMINISTERED INTO HUMAN BODY THROUGH INJECTION, INGESTION, ANY OTHER ROUTE Source text: https://bit.ly/3cHBvkY Further company coverage:

BRIEF-Reckitt Looks To Up Capacity Of Disinfectants, Sanitisers, Soaps In 2020

* RECKITT BENCKISER - ANNOUNCING LAUNCH OF THE RB FIGHT FOR ACCESS FUND TO IMPROVE ACCESS TO HEALTH, HYGIENE AND NUTRITION FOR ALL

BRIEF-Reckitt Says Not Aware Of Evidence Ibuprofen Impacts Covid-19 Patients

* RECKITT -AWARE OF SOCIAL MEDIA IN FRANCE CONCERNS ON USE OF STEROIDS & NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS FOR ALLEVIATION OF COVID-19 SYMPTOMS

Reckitt to spend 2 billion pounds on growth after big writedown

Reckitt Benckiser will invest 2 billion pounds ($2.6 billion) to spur growth, its new CEO announced on Thursday, as it reported a 5 billion pound writedown on baby formula maker Mead Johnson.

Reckitt Benckiser sales come in low, unveils 2 bln investment plan

British household goods maker Reckitt Benckiser reported full-year comparable sales at the low end of company forecasts on Thursday, as it suffered from a slowdown in demand for over-the counter medicines in the United States and infant formula in China, its biggest market.

UPDATE 1-Reckitt's HyHo resurgence buys time for new CEO Narasimhan

A reversal of fortune at two of its businesses has bought new Reckitt Benckiser chief executive Laxman Narasimhan some time after pressure for a break-up of the household goods maker.

Reckitt's HyHo resurgence buys time for new CEO Narasimhan

A reversal of fortune at two of its businesses has bought new Reckitt Benckiser chief executive Laxman Narasimhan some time after pressure for a break-up of the household goods maker.

Factbox - Surging sterling's impact on European consumer companies

European consumer companies Reckitt Benckiser <RB.L> and Tate & Lyle <TATE.L> could take an earnings hit of as much as 2.5% from the sterling's surge on British Prime Minister Boris Johnson's resounding election victory on Friday.

Britain's Reckitt Benckiser gives new parents more paid leave

British household goods maker Reckitt Benckiser Group Plc said on Tuesday it was extending its paid leave globally for new mothers from 16 weeks to 26 weeks, but the change will take time to implement in the United States due to regulatory issues.

New York, states reach $700 million settlement with Reckitt over opioid probes

New York and other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up